Navigation Links
Omeros Announces Publication of Data From Antifibrinolytic Program
Date:2/10/2011

PI-2, referred to as KD1, inhibits plasmin but, like Trasylol®, also inhibits kallikrein and Factor XIa. Dr. Bajaj and her colleagues demonstrate that a minimal change to the sequence of the KD1 protein increases its activity against plasmin approximately 6-fold while dramatically reducing its inhibition of kallikrein and Factor XIa by more than 100-fold. Because the variant KD1 proteins developed by the authors and exclusively licensed to Omeros are more selective than Trasylol®, they could provide more effective bleeding control with fewer side effects. Additionally, as a human protein derivative, these agents are expected to reduce the potential for immunological side effects.

The paper shows the variant KD1 reduced blood loss in a rodent model of surgical bleeding by 85 percent relative to saline treatment, demonstrating an antifibrinolytic effect at least equal to Trasylol®. Similar antifibrinolytic activity of a related variant KD1 also controlled by Omeros was confirmed by other researchers using human plasma evaluated by thromboelastography. Thromboelastograms are used clinically to assess the level of fibrinolysis in patients during surgical procedures at risk for extensive blood loss.

Importantly, the authors also found that the variant KD1 does not slow blood clotting as measured by the partial thromboplastin time (aPTT), a standard indicator of blood's ability to coagulate.  Conversely, Trasylol® increased aPTT by 60 percent, which could significantly prolong bleeding in trauma and surgical patients.  

Omeros believes the efficacy and improved selectivity of the variant KD1 provides a novel approach to the control of bleeding from surgery and trauma. Omeros has initiated scale-up activities of its lead antifibrinolytic compound in preparation for clinical trials.  

About Omeros' Antifibrinolytic Program

Omeros is developing a series of novel antifibrinolytic agents for the cont
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Licenses Novel Antifibrinolytic Agents
2. Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing Ureteroscopy
3. Omeros to Host Conference Call Monday, October 25 at 4:00 p.m. ET To Provide Corporate Update
4. Omeros to Present at the BioCentury NewsMakers Conference
5. Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery
6. Omeros Successfully Unlocks Orphan GPCRs
7. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
8. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
9. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
10. Daniel K. Spiegelman Elected to Board of Directors of Omeros
11. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... THE WOODLANDS, Texas , March 2, 2015 /PRNewswire/ ... ), a biopharmaceutical company focused on developing breakthrough treatments ... year end 2014 financial results on Wednesday, March 4, ... hold a conference call and webcast to discuss clinical ... and year end of 2014 at 10:00 a.m. Eastern ...
(Date:3/2/2015)... LOS ANGELES , March 2, 2015 ImmunoCellular Therapeutics, ... report financial results for the year ended December 31, 2014 on ... update conference call and webcast on Thursday, March 12, 2015, at ... Gengos , President and CEO.   , ... international dial-in: (631) 291-4544; conference code 92238648. , , , ...
(Date:3/1/2015)... , March 1, 2015 /CNW Telbec/ -   Ergoresearch ... Laval and known under the « Équilibre, ... for the second quarter Ended on December 31, 2014. ... Canadian currency. Revenues for the second ... 31, 2014 totaled $ 4 095 112 decreasing by 8,8 % compared ...
Breaking Medicine Technology:Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 2ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 2Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 3Second Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended December 31, 2014. 4
(Date:3/2/2015)... What are the best practices for ... When are interviews scheduled, how can physicians best prepare, ... and practicing physicians who are looking for new opportunities ... at the PracticeLink Physician Career Advancement Workshop and Job ... is from 5:30 to 8:30 p.m. at the Marriott-Texas ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Éminence Organic ... skin care, is excited to announce the launch of ... provide an effective, time-saving solution for those with combination ... 2 in 1 divided jar to separate the products, ... Cheek Treatment. The Balancing Moisturizer Duo, also in a ...
(Date:3/1/2015)... 2015 Security Life Insurance Company ... market, announced the addition of stand-alone individual vision ... Insurance launched today, complete with two plan options. ... the VSP® Vision Care network encompassing a strong ... space. The PrimeStar Select Vision plan will use ...
(Date:3/1/2015)... Comparing a new source of vehicle insurance ... Pros portal this year. A broad range of agencies ... are being supplied through the finder at http://quotespros.com/auto-insurance.html ... available for each policy is now provided in exchange ... will first be asked to present their unique zip ...
(Date:3/1/2015)... Ticket Down is a reputable source for authentic ... Field. Deadheads have been anxiously anticipating this blockbuster weekend ... was formed 50 years ago back in the 60s in ... the untimely death of Jerry Garcia in 1995. This ... reggae, rock, bluegrass, folk, space rock and country to become ...
Breaking Medicine News(10 mins):Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 3Health News:Security Life Insurance Company Launches Individual Vision Insurance Product 2Health News:United Auto Insurance Rates Now Quoted at Consumer Insurance Portal Online 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2
... for injuries to the white and gray matter of ... Certain forms of these injuries can be detected in ... Medical Center researchers. Researchers who followed a ... those with neonatal ultrasound abnormalities were at increased risk ...
... (HealthDay News) -- An international team of researchers has identified ... legs syndrome. Restless legs syndrome is a condition in ... the legs, relieved only by movement. One of the most ... loss, daytime fatigue and even depression. In the ...
... we eat more food, but according to new study in ... to eating lessin restaurant settings. "In this research we ... quantity of food consumed," write authors Arul Mishra, Himanshu Mishra, ... City). The authors conducted a field study in a ...
... By Dennis Thompson HealthDay Reporter , WEDNESDAY, ... have taken a hard line against air traffic controllers ... improve air safety, sleep experts say. Studies have ... improving reaction time and critical thinking for people impaired ...
... transplant survival more than doubled in recent years for ... Research Hospital, with patients who lacked genetically matched donors ... to be the best ever reported for leukemia patients ... expected to make transplantation a treatment option for more ...
... initiative, the American Society for Radiation Oncology (ASTRO) has developed ... papers, on the safe use of integrating intensity modulated radiation ... of this white paper is published in the July print ... The full text of the document is available in advance ...
Cached Medicine News:Health News:Abnormal brain ultrasounds in premature infants indicate future risk of psychiatric disorders 2Health News:Size matters: Why do people eat less when they have big forks? 2Health News:Sometimes Sleeping on the Job May Be a Good Thing 2Health News:Sometimes Sleeping on the Job May Be a Good Thing 3Health News:Bone marrow transplant survival more than doubles for young high-risk leukemia patients 2Health News:Bone marrow transplant survival more than doubles for young high-risk leukemia patients 3Health News:ASTRO publishes white paper on IMRT safety 2
Zebras H 2824-Z Healthcare Starter Kit includes everything you need to start printing wristbands today: the H 2824-Z direct thermal printer, a pre-installed Media Adapter Guide, and a roll of adult-s...
... presents only task-critical information to the ... environment. Up to 14 additional computers ... throughout the facility using a dedicated ... personnel and administrators can all access ...
... system is designed to protect a wandering ... becoming lost or injured. Such residents typically ... or have suffered a head injury., At-risk ... their wrist or ankle, and points of ...
... active-RFID-tags can be programmed to ... that a device needs servicing, ... that a patient or staff ... from an ID-tag includes the ...
Medicine Products: